Christian Heidbreder

CIK: 0002014639

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDV

Indivior Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

INDV
Indivior Pharmaceuticals, Inc.
Jul 10, 2026
Sale(S)
Direct
18.6K shares at avg. $41.14$765K
INDV
Indivior Pharmaceuticals, Inc.
Jun 11, 2026
Sale(S)
Direct
18.6K shares at avg. $38.06$707K
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Exercise(M)
Direct
101.5K shares-
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
45.8K shares at avg. $31.98$1.5M
INDV
Indivior Pharmaceuticals, Inc.
Feb 10, 2026
Award(A)
Direct
33.6K shares-
INDV
Indivior Pharmaceuticals, Inc.
Feb 9, 2026
Award(A)
Performance Stock Units
Direct
132.6K shares-

		Type	Shares	Price		Ownership
Jul 10, 2026	INDV Indivior Pharmaceuticals, Inc.	Sale(S)	18,586	$41.14	$764,628	Direct
Jun 11, 2026	INDV Indivior Pharmaceuticals, Inc.	Sale(S)	18,586	$38.06	$707,383	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	101,544	-	$0	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	45,797	$31.98	$1,464,588	Direct
Feb 10, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A)	33,622	-	$0	Direct
Feb 9, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A) Performance Stock Units	132,565	-	-	Direct

1-6 of 6 transactions

About Heidbreder Christian

Heidbreder Christian (SEC CIK 0002014639) files insider reports with the SEC as Chief Scientific Officer of Indivior Pharmaceuticals, Inc. (INDV).

Signal8 holds 5 ownership filings by Heidbreder Christian (1 Form 3, 4 Form 4), filed between Jan 7, 2026 and Jul 13, 2026. Those filings report 6 transactions, from Feb 9, 2026 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Heidbreder Christian's filings is in NORTH CHESTERFIELD, VA.

Recent filings by Heidbreder Christian

Jul 10, 2026: Open-market sale of INDV shares (Form 4, code S).
Jun 11, 2026: Open-market sale of INDV shares (Form 4, code S).
Mar 3, 2026: Option exercise of INDV shares (Form 4, code M).
Mar 3, 2026: Tax withholding of INDV shares (Form 4, code F).
Feb 10, 2026: Grant or award of INDV shares (Form 4, code A).

Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)

Anderson Woodrow D, Chief Accounting Officer
Ciaffoni Joseph, Chief Executive Officer
Preblick Ryan, Chief Financial Officer
Thompson Juliet, Director
Humphreys Keith, Director
Kingsley Stuart A, Director

How to read Form 4 transaction codes